RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
Feb 13, 2020 – Sep 30, 2026
| $10,000 became | CAGR | Max drawdown | Sharpe ratio |
|---|---|---|---|
| $71,024 | 34.42% | −73.29% | 0.78 |
| $10,000 became | $71,024 |
|---|---|
| CAGR | 34.42% |
| Max drawdown | −73.29% |
| Sharpe ratio | 0.78 |
Loading the growth chart…
Growth of $10,000
- RVMD
Trailing returns
| Period | RVMD |
|---|---|
| 1M | −1.26% |
| 3M | +9.60% |
| 6M | +121.40% |
| YTD | +157.70% |
| 1Y | +339.53% |
| 3Y | +95.01% |
| 5Y | +49.47% |
| Since 2020 | +34.42% |
Metrics
| Return | RVMD |
|---|---|
| Final balance | $71,024 |
| Total return | 610.24% |
| CAGR | 34.42% |
| Calendar years | RVMD |
| Best year | 82.10% |
| Worst year | −36.42% |
| Positive years | 3 of 5 |
| Risk | RVMD |
| Max drawdown | −73.29% |
| Longest drawdown | 3.7 years |
| Volatility (annualized) | 64.77% |
| Risk-adjusted | RVMD |
| Sharpe ratio | 0.78 |
| Sortino ratio | 1.18 |
| Calmar ratio | 0.47 |
| Return | RVMD |
|---|---|
| Final balance | $71,024 |
| Total return | 610.24% |
| CAGR | 34.42% |
| Calendar years | RVMD |
| Best year | 82.10% |
| Worst year | −36.42% |
| Positive years | 3 of 5 |
| Risk | RVMD |
|---|---|
| Max drawdown | −73.29% |
| Longest drawdown | 3.7 years |
| Volatility (annualized) | 64.77% |
| Risk-adjusted | RVMD |
| Sharpe ratio | 0.78 |
| Sortino ratio | 1.18 |
| Calmar ratio | 0.47 |
Worst drawdowns
| Decline | Peak | Bottom | Recovered |
|---|---|---|---|
| −73.3% | Feb 2021 | May 2022 | Nov 2024 |
| −48.6% | Nov 2024 | Apr 2025 | Nov 2025 |
| −42.5% | Jun 2020 | Jul 2020 | Oct 2020 |
| −42.3% | Mar 2020 | Apr 2020 | May 2020 |
| −33.6% | Oct 2020 | Oct 2020 | Feb 2021 |
Annual returns
| Year | RVMD |
|---|---|
| 2020from Feb 13 | +36.99% |
| 2021 | −36.42% |
| 2022 | −5.36% |
| 2023 | +20.40% |
| 2024 | +52.51% |
| 2025 | +82.10% |
| 2026to Sep 30 | +157.70% |